Prostate Cancer Care at Blount Memorial

Learn about screenings, diagnostics, treatment and resources

Prostate cancer is the second-leading cause of cancer death for men in the United States. According to the National Cancer Institute, more than 32,000 U.S. men die of prostate cancer each year. If detected early, however, minimally invasive options usually can treat the cancer and restore body function. Early prostate cancer typically causes no symptoms and most often is found by a prostate-specific antigen (PSA) blood test and digital rectal exam (DRE).

Screening Guidelines: The American Urological Association (AUA) recommends that men age 40 and older (who have a life expectancy of at least 10 years) discuss the benefits and risks of having a prostate-specific antigen (PSA) test. Since the future risk of prostate cancer is related closely to a man's PSA score, a baseline PSA level above the median for age 40 is a strong predictor of prostate cancer. The AUA believes that–when offered and interpreted appropriately–the PSA test may provide essential information for the diagnosis, pre-treatment staging or risk assessment and post-treatment monitoring of prostate cancer.

Blount Memorial Prostate Cancer Resources

• Radioactive Seed Implantation Therapy
• Robotic-assisted surgery

Blount Memorial Prostate Cancer Specialists

• Urologists
• Pathologists
• Radiation Oncologists
• Radiologists
• Surgeons
• Surgical Oncologists